Thryv Quarterly Cash Flow Statements Chart
Quarterly
|
Annual
Thryv Quarterly Cash Flow Statements Table
Quarterly
|
Annual
Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-12-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-12-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities | |||||||||||||||||||||||||||||
net income | 13,931,000 | -9,618,000 | 5,548,000 | 8,424,000 | -27,046,000 | 15,978,000 | 9,314,000 | -50,445,000 | 13,280,000 | 58,002,000 | 33,511,000 | 5,088,000 | 35,624,000 | 24,359,000 | 36,506,000 | 109,800,000 | -560,000,000 | -132,000,000 | |||||||||||
adjustments to reconcile net income to net cash from operating activities: | |||||||||||||||||||||||||||||
depreciation and amortization | 10,191,000 | 11,516,000 | 11,645,000 | 12,519,000 | 14,072,000 | 14,553,000 | 15,842,000 | 15,667,000 | 15,431,000 | 22,438,000 | 23,393,000 | 20,592,000 | 21,969,000 | 24,798,000 | 31,049,000 | 29,908,000 | 19,718,000 | 35,640,000 | 101,000,000 | 103,000,000 | 106,000,000 | 160,000,000 | 161,000,000 | 161,000,000 | 161,000,000 | 241,000,000 | 242,000,000 | ||
amortization of deferred commissions | 3,445,000 | 3,499,000 | 4,032,000 | 4,627,000 | 4,775,000 | 4,849,000 | 5,272,000 | ||||||||||||||||||||||
amortization of debt issuance costs | 818,000 | 830,000 | 871,000 | 896,000 | 945,000 | 1,310,000 | 1,359,000 | 1,360,000 | 1,361,000 | 1,422,000 | 1,444,000 | 1,442,000 | 1,441,000 | 1,488,000 | 1,501,000 | 1,497,000 | 433,000 | 267,000 | |||||||||||
deferred income taxes | 5,296,000 | -2,986,000 | 6,553,000 | 12,237,000 | -20,950,000 | -3,110,000 | 9,943,000 | -7,460,000 | -1,675,000 | 8,103,000 | -6,470,000 | -11,081,000 | -5,671,000 | 37,385,000 | -6,384,000 | -38,190,000 | -13,249,000 | -104,983,000 | |||||||||||
benefit from credit losses and service credits | 5,238,000 | 3,782,000 | 6,012,000 | 4,317,000 | 4,704,000 | 7,475,000 | 4,014,000 | 5,825,000 | 5,755,000 | 7,646,000 | 5,282,000 | 7,576,000 | 5,467,000 | ||||||||||||||||
stock-based compensation expense | 6,008,000 | 7,737,000 | 6,465,000 | 6,011,000 | 6,353,000 | 5,289,000 | 5,462,000 | 5,798,000 | 5,393,000 | 4,488,000 | 4,402,000 | 3,810,000 | 1,928,000 | 1,862,000 | 2,340,000 | 1,921,000 | 1,971,000 | 1,000,000 | 0 | 1,000,000 | 2,000,000 | 0 | 0 | 1,000,000 | |||||
other components of net periodic pension cost | 778,000 | 768,000 | 1,581,000 | 1,581,000 | 1,581,000 | 1,902,000 | 1,865,000 | 121,000 | -453,000 | 10,924,000 | |||||||||||||||||||
(gain) loss on foreign currency exchange rates | -881,000 | 2,856,000 | -2,825,000 | ||||||||||||||||||||||||||
loss on early extinguishment of debt | 0 | 0 | 299,000 | ||||||||||||||||||||||||||
other | 393,000 | -355,000 | 4,097,000 | 3,000 | -18,000 | -3,152,000 | -756,000 | -3,355,000 | -312,000 | -639,000 | 1,440,000 | -288,000 | 609,000 | -23,000 | 6,000 | ||||||||||||||
changes in working capital items, excluding acquisitions: | |||||||||||||||||||||||||||||
accounts receivable | -1,448,000 | 16,840,000 | 5,006,000 | 17,238,000 | 10,673,000 | -9,750,000 | 34,163,000 | 8,807,000 | 16,268,000 | 3,688,000 | 1,368,000 | 2,063,000 | -12,361,000 | 25,577,000 | -21,700,000 | 43,645,000 | 26,846,000 | 25,640,000 | 1,000,000 | 7,000,000 | 4,000,000 | -6,000,000 | 12,000,000 | -2,000,000 | 37,000,000 | ||||
contract assets | -684,000 | 147,000 | 6,942,000 | -950,000 | -3,540,000 | -1,670,000 | 274,000 | 374,000 | 463,000 | 538,000 | 433,000 | 508,000 | 1,285,000 | 1,791,000 | 1,435,000 | 956,000 | 1,446,000 | 1,172,000 | |||||||||||
prepaid expenses and other assets | 4,716,000 | -20,672,000 | 8,218,000 | 3,535,000 | 7,555,000 | -18,169,000 | 13,399,000 | 24,769,000 | -14,679,000 | -13,967,000 | 8,563,000 | 14,842,000 | -6,920,000 | 9,268,000 | 4,383,000 | 3,431,000 | -10,998,000 | ||||||||||||
accounts payable and accrued liabilities | 1,823,000 | -22,338,000 | -12,418,000 | -16,536,000 | 8,182,000 | -5,754,000 | -24,815,000 | -32,139,000 | -6,515,000 | -4,149,000 | -7,484,000 | -19,697,000 | -9,775,000 | -61,506,000 | -13,244,000 | 16,325,000 | -67,458,000 | -19,416,000 | -20,000,000 | -19,000,000 | -47,000,000 | 33,000,000 | -19,000,000 | -1,000,000 | -40,000,000 | -5,000,000 | -25,000,000 | ||
other liabilities | -18,162,000 | 369,000 | 1,319,000 | 3,697,000 | -23,074,000 | 1,189,000 | 5,098,000 | -31,941,000 | 2,711,000 | 3,044,000 | 5,556,000 | -38,504,000 | 3,303,000 | ||||||||||||||||
net cash from operating activities | 29,556,000 | -10,481,000 | 26,143,000 | 35,980,000 | 22,222,000 | 5,438,000 | 45,912,000 | 25,425,000 | 32,311,000 | 44,352,000 | 47,318,000 | 27,576,000 | 29,327,000 | 49,032,000 | 39,737,000 | 67,598,000 | 14,204,000 | 58,182,000 | 63,000,000 | 90,000,000 | 46,000,000 | 83,000,000 | 103,000,000 | 102,000,000 | 100,000,000 | 110,000,000 | 111,000,000 | ||
cash flows from investing activities | |||||||||||||||||||||||||||||
additions to fixed assets and capitalized software | -7,770,000 | -7,085,000 | -8,807,000 | -8,500,000 | -8,952,000 | -7,278,000 | -8,904,000 | -8,880,000 | -5,136,000 | -9,888,000 | -9,697,000 | -5,649,000 | -3,999,000 | -6,796,000 | -5,738,000 | -10,647,000 | -3,668,000 | -10,727,000 | -2,000,000 | -6,000,000 | -3,000,000 | -3,000,000 | -6,000,000 | -6,000,000 | -3,000,000 | -3,000,000 | -9,000,000 | ||
net cash from investing activities | -7,770,000 | -7,228,000 | -85,694,000 | -8,500,000 | -8,952,000 | -7,278,000 | 10,000,000 | -6,000,000 | -3,000,000 | -9,000,000 | |||||||||||||||||||
cash flows from financing activities | |||||||||||||||||||||||||||||
proceeds from term loan | -28,036,000 | 0 | |||||||||||||||||||||||||||
proceeds from term loan, related party | 28,036,000 | 0 | |||||||||||||||||||||||||||
payments of term loan | -11,467,000 | -26,497,000 | -309,286,000 | -9,368,000 | -42,500,000 | -17,500,000 | -35,000,000 | -31,001,000 | -36,336,000 | -21,384,000 | -15,444,000 | ||||||||||||||||||
payments of term loan, related party | -14,783,000 | -12,378,000 | 0 | -2,675,000 | -3,616,000 | -2,056,000 | |||||||||||||||||||||||
proceeds from abl facility | 96,670,000 | 109,647,000 | 81,425,000 | 17,500,000 | 24,728,000 | 205,351,000 | 213,761,000 | 210,616,000 | 272,857,000 | 229,607,000 | 258,142,000 | 186,173,000 | 302,374,000 | 252,645,000 | 247,795,000 | 295,873,000 | 249,936,000 | 274,889,000 | |||||||||||
payments of abl facility | -94,544,000 | -95,748,000 | -79,433,000 | -13,600,000 | -62,465,000 | -198,459,000 | -224,645,000 | -214,571,000 | -255,179,000 | -233,908,000 | -255,896,000 | -192,539,000 | -279,327,000 | -268,897,000 | -249,636,000 | -281,533,000 | -285,492,000 | -277,291,000 | |||||||||||
debt issuance costs | 0 | -161,000 | |||||||||||||||||||||||||||
purchase of treasury stock | 0 | 0 | 0 | ||||||||||||||||||||||||||
net cash from financing activities | -22,339,000 | 12,279,000 | 64,662,000 | -34,932,000 | -8,956,000 | -1,558,000 | -17,055,000 | -33,401,000 | -36,215,000 | -27,867,000 | 6,386,000 | -48,429,000 | -35,962,000 | -68,317,000 | 191,796,000 | ||||||||||||||
effect of exchange rate changes on cash, cash equivalents and restricted cash | 468,000 | 124,000 | -1,224,000 | 328,000 | 275,000 | -723,000 | |||||||||||||||||||||||
increase in cash, cash equivalents and restricted cash | 4,589,000 | -4,121,000 | |||||||||||||||||||||||||||
cash, cash equivalents and restricted cash, beginning of period | 0 | 17,760,000 | 0 | 0 | 0 | 20,530,000 | |||||||||||||||||||||||
cash, cash equivalents and restricted cash, end of period | -85,000 | 12,454,000 | 3,887,000 | -7,124,000 | 4,589,000 | 16,409,000 | |||||||||||||||||||||||
supplemental information | |||||||||||||||||||||||||||||
cash paid for interest | 8,224,000 | 8,256,000 | 8,719,000 | 10,921,000 | 12,467,000 | 11,911,000 | 14,437,000 | 14,584,000 | 15,008,000 | 14,649,000 | 17,520,000 | 12,949,000 | 11,966,000 | 14,246,000 | 14,883,000 | 16,086,000 | |||||||||||||
cash paid for income taxes | 2,195,000 | 1,178,000 | 453,000 | 1,617,000 | 186,000 | 4,586,000 | 16,739,000 | 21,513,000 | 15,421,000 | 5,402,000 | 20,080,000 | 9,042,000 | |||||||||||||||||
acquisition of a business, net of cash acquired | -143,000 | 0 | 0 | -16,000 | -774,000 | -22,003,000 | 0 | -1,180,000 | 0 | -174,190,000 | |||||||||||||||||||
(decrease) in cash, cash equivalents and restricted cash | -5,306,000 | ||||||||||||||||||||||||||||
other components of net periodic pension benefit | |||||||||||||||||||||||||||||
impairment charges | 0 | 102,000,000 | 0 | 0 | 0 | 5,497,000 | |||||||||||||||||||||||
non-cash gain from the remeasurement of the indemnification asset | 0 | ||||||||||||||||||||||||||||
bargain purchase gain | -638,000 | -3,240,000 | 292,000 | -7,297,000 | |||||||||||||||||||||||||
proceeds from exercise of stock warrants | |||||||||||||||||||||||||||||
proceeds from common stock offering, net of offering expenses | |||||||||||||||||||||||||||||
non-cash investing and financing activities | |||||||||||||||||||||||||||||
repurchase of treasury stock as a result of the settlement of the indemnification asset | 0 | ||||||||||||||||||||||||||||
net | -67,000,000 | -42,000,000 | -59,000,000 | -59,000,000 | -85,000,000 | -82,000,000 | |||||||||||||||||||||||
adjustments to reconcile net (loss) to net cash from operating activities: | |||||||||||||||||||||||||||||
loss on foreign currency exchange rates | 1,077,000 | ||||||||||||||||||||||||||||
non-cash income from the remeasurement of the indemnification asset | |||||||||||||||||||||||||||||
gain on foreign currency exchange rates | -1,222,000 | 2,373,000 | 1,045,000 | 835,000 | |||||||||||||||||||||||||
cash paid (received) for income taxes | 1,915,000 | ||||||||||||||||||||||||||||
net cash (used in) investing activities | -8,902,000 | -17,994,000 | -5,136,000 | -9,888,000 | -9,713,000 | -6,423,000 | -26,002,000 | -1,215,000 | -6,918,000 | -10,584,000 | -177,858,000 | -10,727,000 | -2,000,000 | -1,000,000 | -3,000,000 | -3,000,000 | |||||||||||||
net cash (used in) financing activities | -37,187,000 | -46,820,000 | -60,000,000 | -69,000,000 | -43,000,000 | -67,000,000 | -98,000,000 | -129,000,000 | -74,000,000 | -185,000,000 | -112,000,000 | ||||||||||||||||||
effect of exchange rate changes on cash and cash equivalents | 50,000 | -290,000 | 783,000 | -983,000 | -1,168,000 | 541,000 | 1,513,000 | -2,627,000 | -112,000 | -707,000 | |||||||||||||||||||
increase in cash and cash equivalents and restricted cash | -10,415,000 | 9,830,000 | 1,846,000 | 407,000 | -7,882,000 | 10,252,000 | 901,000 | -5,770,000 | |||||||||||||||||||||
cash and cash equivalents and restricted cash, beginning of period | 0 | 18,180,000 | 0 | 0 | 0 | 13,557,000 | 0 | 0 | |||||||||||||||||||||
cash and cash equivalents and restricted cash, end of period | -10,415,000 | 28,010,000 | 1,846,000 | 407,000 | -7,882,000 | 23,809,000 | 901,000 | -5,770,000 | |||||||||||||||||||||
cash (received) paid for income taxes | -992,000 | ||||||||||||||||||||||||||||
other components of net periodic pension (benefit) cost | -13,831,000 | -273,000 | |||||||||||||||||||||||||||
proceeds from the sale of assets | |||||||||||||||||||||||||||||
payments of senior term loan | 0 | 0 | 0 | -335,821,000 | -41,118,000 | ||||||||||||||||||||||||
payments of senior term loan, related party | 0 | 0 | 0 | -113,789,000 | -13,882,000 | ||||||||||||||||||||||||
proceeds from exercises of stock options and stock warrants | 1,901,000 | 550,000 | 3,499,000 | 839,000 | |||||||||||||||||||||||||
other components of net periodic pension | 3,928,000 | -9,153,000 | -70,000 | ||||||||||||||||||||||||||
proceeds from the sale of fixed assets | |||||||||||||||||||||||||||||
benefit from credit losses | 4,820,000 | 2,919,000 | -1,726,000 | 2,018,000 | |||||||||||||||||||||||||
benefit from service credits | 768,000 | 1,876,000 | 4,191,000 | 4,528,000 | 4,282,000 | ||||||||||||||||||||||||
loss on termination of leaseback obligations | 0 | 0 | |||||||||||||||||||||||||||
(gain) loss on disposal/write-off of fixed assets and capitalized software | -5,492,000 | 0 | |||||||||||||||||||||||||||
non-cash (gain) income from remeasurement of indemnification asset | 1,247,000 | -404,000 | |||||||||||||||||||||||||||
operating lease liability | -1,004,000 | 41,000 | -2,004,000 | -403,000 | -8,000 | ||||||||||||||||||||||||
contract liabilities | 17,061,000 | 3,863,000 | -15,704,000 | 2,547,000 | 174,000 | ||||||||||||||||||||||||
settlement of stock option liability | 0 | ||||||||||||||||||||||||||||
proceeds from new term loan | 0 | 0 | 0 | 418,070,000 | |||||||||||||||||||||||||
proceeds from new term loan, related party | 0 | 0 | 0 | 260,930,000 | |||||||||||||||||||||||||
payments of new tern loan | -24,016,000 | -24,110,000 | |||||||||||||||||||||||||||
payments of new term loan, related party | -10,984,000 | -10,890,000 | |||||||||||||||||||||||||||
proceeds from senior term loan | |||||||||||||||||||||||||||||
proceeds from senior term loan, related party | |||||||||||||||||||||||||||||
proceeds from exercise of stock options | |||||||||||||||||||||||||||||
proceeds from private placement | |||||||||||||||||||||||||||||
payments of lease obligations | |||||||||||||||||||||||||||||
accrued income taxes | -6,339,000 | 9,597,000 | -22,365,000 | ||||||||||||||||||||||||||
proceeds from the sale of building and fixed assets | 0 | ||||||||||||||||||||||||||||
loss on disposal/write-off of fixed assets and capitalized software | 15,000 | 68,000 | |||||||||||||||||||||||||||
non-cash income from remeasurement of indemnification asset | |||||||||||||||||||||||||||||
increase in cash and cash equivalents | 27,435,000 | 1,000,000 | 26,000,000 | -1,000,000 | -33,000,000 | 23,000,000 | -78,000,000 | -10,000,000 | |||||||||||||||||||||
stock-based compensation (benefit) expense | 1,300,000 | ||||||||||||||||||||||||||||
non-cash gain from remeasurement of indemnification asset | |||||||||||||||||||||||||||||
prepaid and other assets | 7,757,000 | ||||||||||||||||||||||||||||
payments of original term facility, upon extinguishment | |||||||||||||||||||||||||||||
payments of original term facility, upon extinguishment, related party | |||||||||||||||||||||||||||||
payments of original term facility, prior to extinguishment | |||||||||||||||||||||||||||||
payments of original term facility, prior to extinguishment, related party | |||||||||||||||||||||||||||||
cash and cash equivalents, beginning of period | 0 | 0.1 | |||||||||||||||||||||||||||
cash and cash equivalents, end of period | 635,000 | 1,000,000 | 20,000,000 | 171,000,000 | -1,000,000 | -33,000,000 | 179,000,000 | -10,000,000 | 243,999,999.9 | 0.1 | |||||||||||||||||||
benefit from bad debt | |||||||||||||||||||||||||||||
deferred costs | |||||||||||||||||||||||||||||
payments of financing obligations | |||||||||||||||||||||||||||||
(decrease) in cash and cash equivalents | |||||||||||||||||||||||||||||
reconciliation of net (loss) to net cash from operating activities: | |||||||||||||||||||||||||||||
benefit from deferred income taxes | -10,000,000 | -1,000,000 | -3,000,000 | 15,000,000 | 1,000,000 | -2,000,000 | -3,000,000 | -119,000,000 | |||||||||||||||||||||
benefit from unrecognized tax benefits | -2,000,000 | -4,000,000 | |||||||||||||||||||||||||||
benefit from bad debts | 7,000,000 | 3,000,000 | 5,000,000 | 6,000,000 | 5,000,000 | 9,000,000 | 6,000,000 | 3,000,000 | 8,000,000 | ||||||||||||||||||||
non-cash interest expense | 29,000,000 | 28,000,000 | 25,000,000 | 24,000,000 | 24,000,000 | 23,000,000 | 22,000,000 | ||||||||||||||||||||||
employee retiree benefits | 5,000,000 | 1,000,000 | 1,000,000 | -3,000,000 | 11,000,000 | -1,000,000 | -15,000,000 | 0 | -2,000,000 | ||||||||||||||||||||
employee benefit plan amendments | 0 | ||||||||||||||||||||||||||||
gains on early extinguishment of debt | 0 | ||||||||||||||||||||||||||||
changes in assets and liabilities: | |||||||||||||||||||||||||||||
deferred directory costs | 15,000,000 | 14,000,000 | 11,000,000 | 2,000,000 | 16,000,000 | 3,000,000 | 5,000,000 | -3,000,000 | -23,000,000 | ||||||||||||||||||||
other current assets | 2,000,000 | 3,000,000 | 3,000,000 | 0 | 5,000,000 | 2,000,000 | 1,000,000 | ||||||||||||||||||||||
other items | -2,000,000 | -6,000,000 | -2,000,000 | -5,000,000 | 4,000,000 | 11,000,000 | |||||||||||||||||||||||
sales of fixed assets | 0 | ||||||||||||||||||||||||||||
debt repayments | -60,000,000 | -69,000,000 | -38,000,000 | -67,000,000 | -98,000,000 | -128,000,000 | -74,000,000 | -184,000,000 | -112,000,000 | ||||||||||||||||||||
debt issuance costs and other financing items | 0 | 0 | -5,000,000 | 0 | 0 | ||||||||||||||||||||||||
cash and cash equivalents, beginning of year | 0 | 0 | 171,000,000 | 0 | 0 | 0 | 156,000,000 | 0 | 0 | ||||||||||||||||||||
cash interest on debt | 55,000,000 | 56,000,000 | 66,000,000 | 60,000,000 | 71,000,000 | 64,000,000 | 74,000,000 | 72,000,000 | 96,000,000 | ||||||||||||||||||||
cash income taxes | 0 | 4,000,000 | 3,000,000 | 0 | 2,000,000 | -1,000,000 | 0 | ||||||||||||||||||||||
gain on early extinguishment of debt | |||||||||||||||||||||||||||||
reconciliation of net income to net cash from operating activities: | |||||||||||||||||||||||||||||
impairment charge | |||||||||||||||||||||||||||||
non-cash reorganization items | 0 | 0 | |||||||||||||||||||||||||||
cash acquired in acquisition | 0 | ||||||||||||||||||||||||||||
proceeds from sale of building | |||||||||||||||||||||||||||||
cash and cash equivalents, end of year | |||||||||||||||||||||||||||||
gain on sale of assets | |||||||||||||||||||||||||||||
cash acquired in acquisition and other | |||||||||||||||||||||||||||||
amortization of debt discount | 17,000,000 | ||||||||||||||||||||||||||||
other non-cash interest expense | 6,000,000 | ||||||||||||||||||||||||||||
accounts receivable and unbilled accounts receivable | 136,000,000 | ||||||||||||||||||||||||||||
change in cash and cash equivalents |
We provide you with 20 years of cash flow statements for Thryv stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Thryv stock. Explore the full financial landscape of Thryv stock with our expertly curated income statements.
The information provided in this report about Thryv stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.